Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
Italy's biggest conglomerate, Intesa Sanpaolo, has paid 360 million euros ($382 million) in cash to acquire a 26.2% stake in health insurer Intesa Sanpaolo RBM Salute, which it does not own. that it will be used.
Read Full NewsResearchers compare enzalutamide vs abiraterone in the metastatic castration-sensitive prostate cancer setting.
A new study assesses breast and ovarian cancer risk in women who carry a BRCA variant of uncertain significance or have a noninformative negative result.
1.
According to the Lancet, having cancer and VTE at the same time increases mortality risk.
2.
When performed by skilled surgeons, robotic surgery for pancreatic tumors is safe and feasible.
3.
Research indicates that extended PSMA therapy is safe and effective for patients with prostate cancer.
4.
An Examine More Into the Acceptance of CRISPR/Cas9 Gene Therapy for Sickle Cell Illness.
5.
Australian researchers attribute drop in melanoma rates to increasingly diverse population
1.
Precision Medicine in Modern Cancer Therapy
2.
Mastering Oncology RCM: Reducing Errors, Denials & Improving Billing Efficiency
3.
The Transformative Power of Genomics in the Diagnosis and Management of Rare Cancers
4.
Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors
5.
The Genetics of Bernard Soulier Syndrome: What We Know so Far
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion
3.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
4.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
5.
From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge